HCV Core Proteins Change TGF-Beta Responses in Liver Cancer
Author Information
Author(s): Battaglia Serena, Benzoubir Nassima, Nobilet Soizic, Charneau Pierre, Samuel Didier, Zignego Anna Linda, Atfi Azeddine, Bréchot Christian, Bourgeade Marie-Françoise
Primary Institution: Inserm, Unité 785, Villejuif, France
Hypothesis
The study investigates how HCV core proteins affect TGF-β signaling in liver cancer progression.
Conclusion
HCV core proteins can shift TGF-β responses from tumor suppression to promoting epithelial-mesenchymal transition (EMT).
Supporting Evidence
- HCV core protein expression reduces TGF-β-induced cell growth inhibition.
- HCV core proteins promote EMT in hepatocytes.
- Different HCV core variants interact differently with Smad3.
Takeaway
This study shows that a virus can change how a protein in the body works, making it help cancer grow instead of stopping it.
Methodology
The study used primary human and mouse hepatocytes to analyze the effects of HCV core proteins on TGF-β signaling.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website